Eisai eyes fiscal 2025 U.S. approval for home version of Alzheimer’s drug 2025-01-22T18:04:06-05:00January 22nd, 2025| share this article![#item_full_content] Read More share this article! Related Posts China directs state capital into A shares to anchor stock market January 23rd, 2025 Rising US-China tensions top concerns of American firms in China: AmCham China January 23rd, 2025 HKMA and AMCM launch direct linkage for cross-border bond investment January 23rd, 2025 SK Hynix’s profit slows as Chinese output weighs on memory market January 23rd, 2025
